US Clinical Chemistry & Immunodiagnostic Market Opportunities Investigated in New VPG Report Available at MarketPublishers.com

  US Clinical Chemistry & Immunodiagnostic Market Opportunities Investigated
  in New VPG Report Available at MarketPublishers.com

Business Wire

LONDON -- February 22, 2013

In the years ahead, the clinical chemistry and immunodiagnostics markets will
see a remarkable metamorphosis worldwide, with the US being no exception. This
transformation is likely to be brought about by the convergence of tighter
regulations; advancements in diagnostic technologies, system engineering,
automation and IT; as well as intense competition. The routine chemistry
segment, for example, will be reminiscent of commodity markets, where market
positioning and cost per test are of more importance than the technology
itself.

Some of the top US market participants include, among others, Abbott
Laboratories, Roche, Beckman Siemens, Biomedical Diagnostics, BioMerieux,
Bio-Rad, Sysmex, Dako, Eiken, Fujirebio, Instrumentation Laboratory, Kyowa
Medex, Matritech, Ortho-Clinical Diagnostics.

New report “Competing in the US Clinical Chemistry and Immunodiagnostic
Markets”  elaborated by Venture Planning Group (VPG) offers a comprehensive
guide to the US clinical chemistry and immunodiagnostic laboratory practice
during the next five years.

Report Features:

  *insight into key economic, regulatory, demographic, social and
    technological trends with huge market impact in future;
  *volume and sales forecasts for over 100 clinical chemistry, TDM,
    endocrine, cancer, immunoprotein and abused drug assays;
  *volume forecasts for specimens;
  *reagent and instrument sales forecasts;
  *review of current instrumentation technologies, with a feature comparison
    of 50 analyzers;
  *sales and market shares of top reagent and instrument suppliers;
  *analysis of existent and emerging technologies with their potential market
    applications;
  *product development opportunities for clinical chemistry and
    immunodiagnostic instruments and consumables;
  *profiles of 25 current and emerging suppliers;
  *review of market penetration strategies, entry barriers and risks.

Report Details:

Title: Competing in the US Clinical Chemistry and Immunodiagnostic Markets

Published:  February, 2013

Pages: 600

Price:  US$ 11,500.00

http://marketpublishers.com/report/diagnostics-diseases/in_vitro_diagnostics/competing-in-us-clinical-chemistry-n-immunodiagnostic-markets.html

More US Diagnostics & Diseases Market Reports by VPG Include:

  *Competing in the US Infectious Disease Testing Market
  *Competing in the US Hematology and Flow Cytometry Markets
  *Competing in the US Molecular Diagnostics Market
  *Competing in the US Coagulation Market
  *Competing in the US Clinical Chemistry and Immunodiagnostic Markets
  *Competing in the US Cancer Diagnostics Market

More new reports by VPG can be found at
http://marketpublishers.com/members/vpg/info.html

Contact:

The Market Publishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com
 
Press spacebar to pause and continue. Press esc to stop.